Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Multiple Myeloma: Results of the Z-MARK Study
Noopur, R., Vescio, R., Montgomery, C. W., Badros, A. Z., Munshi, N. C., Orlowski, R., Hadala, J. T., Warsi, G., Argonza-Aviles, E., Ericson, S. G., Anderson, K. C.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-1864
Date:
December, 2015
File:
PDF, 1.23 MB
english, 2015